Irish healthcare R&D gets Euro10m boost:
This article was originally published in Clinica
Ireland's Health Research Board has been awarded Euro10m ($12.3m) capital funding in 2005, taking its annual revenue budget to Euro27m, up more than 300% since 1999. The allocation seeks to support the recommendations of a 2001 health research strategy report, highlighting the importance of improving R&D in increasing the effectiveness and efficiency of Ireland's health service.
You may also be interested in...
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.
Johnson & Johnson believes personalization via digital holds the key to smoking cessation success as it launches in the UK its app-supported Nicorette QuickMist SmartTrack product.